Jason Harris

1 presentation

• W115. ELUNETIROM, A FIRST-IN-CLASS, BRAIN-TARGETING, ANTIDEPRESSANT CANDIDATE IN PH2 DEVELOPMENT, TRIGGERS ROBUST BIOENERGETIC AND NEUROPLASTIC IMPROVEMENTS IN PRECLINICAL STUDIES

  2026 ASCP Annual Meeting